| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0961203306071670 |
| P2093 | author name string | ES Stroes | |
| JJP Kastelein | |||
| MR Hayden | |||
| SI Van Leuven | |||
| P2860 | cites work | The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression | Q46453782 |
| Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL/lpr mice | Q46714189 | ||
| Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension | Q46749505 | ||
| The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease | Q46831359 | ||
| The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury | Q46859216 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes | Q46905045 | ||
| Antigen-independent targeting of long-lived CD4+ cytolytic T effector cells to lesions of atherosclerosis. | Q51984359 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models | Q24810773 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly | Q29547442 | ||
| MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. | Q33844451 | ||
| Enzymatic function of nitric oxide synthases | Q33847576 | ||
| Myeloperoxidase and cardiovascular disease. | Q34406359 | ||
| Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization | Q34448710 | ||
| Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 | ||
| Adhesion molecules and atherosclerosis | Q35581561 | ||
| Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease | Q35599842 | ||
| Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk | Q35876331 | ||
| Mechanisms of action of mycophenolate mofetil | Q36085841 | ||
| Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles? | Q36313446 | ||
| Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease | Q36386686 | ||
| IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
| Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions | Q37375378 | ||
| Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil | Q38324351 | ||
| Effects of mycophenolic acid on endothelial cells | Q40435492 | ||
| Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines | Q40933631 | ||
| Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production | Q41908710 | ||
| Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil | Q42673867 | ||
| In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice | Q43669472 | ||
| In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells | Q43695984 | ||
| Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats | Q43852739 | ||
| Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil | Q43923268 | ||
| Subendothelial retention of atherogenic lipoproteins in early atherosclerosis | Q44029239 | ||
| The immunosuppressive drug mycophenolic acid reduces endothelin-1 synthesis in endothelial cells and renal epithelial cells | Q44112427 | ||
| Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection | Q44146546 | ||
| Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction | Q44471173 | ||
| Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice | Q44545474 | ||
| Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil | Q44625514 | ||
| The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients | Q44701667 | ||
| Sequential therapies for proliferative lupus nephritis | Q44785533 | ||
| Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation | Q44940055 | ||
| Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. | Q46174852 | ||
| P433 | issue | 11_suppl | |
| P304 | page(s) | 11-17 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis? | |
| P478 | volume | 15 |
Search more.